Cargando…

Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO

OBJECTIVE: To assess the clinical relevance of the differential binding of antibodies against the 2 main aquaporin-4 (AQP4) isoforms in neuromyelitis optica (NMO) patient sera using stably transfected human embryonic kidney cells. METHODS: Flow cytometry of human embryonic kidney cells stably transf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitley, Joanna, Woodhall, Mark, Leite, M. Isabel, Palace, Jackie, Vincent, Angela, Waters, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476052/ https://www.ncbi.nlm.nih.gov/pubmed/26140280 http://dx.doi.org/10.1212/NXI.0000000000000121

Ejemplares similares

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
por: Yeo, Tianrong, et al.
Publicado: (2019)

Identification of geraldol as an inhibitor of aquaporin-4 binding by NMO-IgG
por: Wang, Jie, et al.
Publicado: (2020)

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
por: Zeka, Bleranda, et al.
Publicado: (2016)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
por: Wilson, Robert, et al.
Publicado: (2018)

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study
por: Valentino, Paola, et al.
Publicado: (2016)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
por: Kinoshita, Makoto, et al.
Publicado: (2012)

Finding NMO
por: Daneman, Richard
Publicado: (2016)

Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders
por: Sánchez Gomar, Ismael, et al.
Publicado: (2016)

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
por: Mader, Simone, et al.
Publicado: (2010)

Therapy of NMO spectrum disorders
por: Biswas, Atanu, et al.
Publicado: (2015)

Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCE(NMO) Study
por: Hümmert, Martin W., et al.
Publicado: (2022)

Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease
por: Mariano, Romina, et al.
Publicado: (2019)

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS
por: Zeka, Bleranda, et al.
Publicado: (2015)

Neurodegeneration in MS and NMO: The Eye and the Blood
por: Petzold, Axel, et al.
Publicado: (2011)

Neuromyelitis optica (NMO) and autoimmune thyroiditis
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes
por: Tsymala, Irina, et al.
Publicado: (2020)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, Patrick, et al.
Publicado: (2016)

Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder
por: Camera, Valentina, et al.
Publicado: (2021)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

Autoimmune Myelitis and Myocarditis in a Patient With Anti-Aquaporin-4, Antinuclear, and Antiphospholipid Autoantibodies: The Neuromyelitis Optica-Systemic Lupus Erythematosus (NMO-SLE) Overlap Syndrome
por: Mader, Edward C, et al.
Publicado: (2022)

Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders
por: Damato, Valentina, et al.
Publicado: (2022)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006)

Wallenda-Nmo Axis Regulates Growth via Hippo Signaling
por: Wang, Xianping, et al.
Publicado: (2021)

Wernicke’s Encephalopathy Precipitated by Area Postrema Syndrome of NMO-SD
por: Anuradha, Mahto, et al.
Publicado: (2023)

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
por: Hacohen, Yael, et al.
Publicado: (2015)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO
por: Gelfand, Jeffrey M., et al.
Publicado: (2014)

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
por: Vaknin-Dembinsky, Adi, et al.
Publicado: (2016)

3D-DIR for early differential diagnostic and prognostic evaluation of NMO
por: Wang, Yanbing, et al.
Publicado: (2016)

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO
por: Higuchi, Osamu, et al.
Publicado: (2016)

COVID-19 infection in NMO/SD patients: a French survey
por: Zeidan, Sinéad, et al.
Publicado: (2020)

An Atypical Presentation of Chronic Inflammatory Myelin Degeneration in Neuromyelitis Optica (NMO)
por: Allu, Sai Vishnu Vardhan, et al.
Publicado: (2023)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
por: Morris, Katrina A., et al.
Publicado: (2015)

Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
por: Camera, Valentina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k8sm2eer6t6r0a6er2sp6gh9kp